American Chipmakers: A Tariff-Driven Shift
President Trump has threatened to impose tariffs of up to 300% on semiconductors to boost domestic production. This creates a potential investment opportunity in U.S.-based semiconductor companies that stand to gain from a shift toward onshore manufacturing.
Your Basket's Financial Footprint
Aggregate market capitalisation breakdown for the 'American Chipmakers: A Tariff-Driven Shift' basket, summarising concentration and investor takeaways.
- Large-cap dominance suggests lower volatility and closer tracking to broad-market trends, likely reducing idiosyncratic risk.
- Better suited as a core holding for diversified portfolios rather than a speculative, high-growth satellite position.
- More likely to provide steady long-term appreciation than rapid, short-term, explosive gains.
NVDA: $4.40T
INTC: $178.03B
AVGO: $1.62T
- Other
About This Group of Stocks
Our Expert Thinking
President Trump's proposed tariffs of up to 300% on semiconductors could create a massive shift towards domestic chip production. This policy-driven catalyst may make imported chips prohibitively expensive, driving unprecedented demand for U.S.-based alternatives and spurring significant capital investment in American facilities.
What You Need to Know
This collection spans the entire semiconductor value chain, from chip designers and manufacturers to equipment suppliers. These companies are positioned to benefit from potential supply chain realignment as businesses seek domestic alternatives to avoid hefty tariffs on imported semiconductors.
Why These Stocks
Each company has been handpicked by professional analysts for their strategic positioning in the U.S. semiconductor ecosystem. They represent firms that could directly capitalise on increased domestic demand and investment in American chip manufacturing infrastructure.
Why You'll Want to Watch These Stocks
Policy-Driven Catalyst
Trump's proposed 300% tariffs could trigger the biggest shift in semiconductor manufacturing in decades. These companies are positioned at the centre of this potential transformation.
Domestic Manufacturing Boom
As companies scramble to avoid massive tariffs, U.S.-based chip manufacturers and equipment suppliers could see unprecedented demand for their services and facilities.
Supply Chain Realignment
This isn't just about tariffs - it's about a fundamental reshaping of global tech supply chains. Early movers in domestic production could capture significant market share.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Drug Pricing Power | Major Pharma Stocks 2025
Following plans by major drugmakers to raise prices on hundreds of medications, the pharmaceutical industry is showcasing its significant pricing power. This development highlights an investment opportunity centered on established pharmaceutical companies capable of translating market dominance into revenue growth.
Automation & Software Investment Theme Overview
Recent labor data reveals a split market, with low private-sector jobless claims contrasting with high unemployment driven by federal layoffs. This dynamic creates an investment opportunity in companies providing automation, software, and efficiency-boosting services as businesses prioritize productivity over expanding their payrolls.
Oyo's IPO Plans: Hospitality Sector Recovery Explained
Global hospitality firm Oyo's parent company has revived its IPO plans, signaling renewed confidence in the travel market. This high-profile listing could ignite investor interest across the entire hospitality and travel technology sector, creating opportunities for related service providers.